Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet

Takahiro Hiraide, Yoshihiko Suzuki, Satoko Yamamoto, Soroku Yagihashi, Motoaki Sano · 2025

Read Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet by Takahiro Hiraide, Yoshihiko Suzuki, Satoko Yamamoto, Soroku Yagihashi, Motoaki Sano (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12750934.txt.

Description

Takahiro Hiraide and co-authors report striking loyalty to a diabetes drug among Japanese patients in a study from 2025. Tirzepatide is a dual-action drug with strong trial results. In Western use, six to ten percent of patients quit, mostly over stomach side effects. The Japanese real-world picture looks far brighter.

Two hundred nineteen patients were followed in routine care. Only about one percent stopped the drug. Food questionnaires showed appetites for fatty, high-calorie foods fell. Patients kept eating low-carb traditional foods such as fish and meat. The authors credit that diet pattern for the gentle ride. Culture and cuisine may decide whether a powerful drug stays usable.

Catalog record

CREATORTakahiro Hiraide, Yoshihiko Suzuki, Satoko Yamamoto, Soroku Yagihashi, Motoaki Sano
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE7 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12750934

Browse the full library · About the Tower of Babel